| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Antioxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum : an overview
Authors:ID Cör Andrejč, Darija (Author)
ID Knez, Željko (Author)
ID Knez Marevci, Maša (Author)
Files:.pdf Antioxidant,_antibacterial,_antit-Andrejc-2022.pdf (1,26 MB)
MD5: 82973125D6DED6DB688E44FE50715F0D
 
URL https://www.frontiersin.org/articles/10.3389/fphar.2022.934982/full
 
Language:English
Work type:Scientific work
Typology:1.02 - Review Article
Organization:FKKT - Faculty of Chemistry and Chemical Engineering
MF - Faculty of Medicine
Abstract:Ganoderma lucidum is a very medicinal mushroom that has been utilized in Oriental medicine for many years. It has a wide range of pharmacological and therapeutic properties, and has been used for many years as a health promoter. It contains various biologically active compounds that improve the immune system and have antioxidant, antitumor, anti-inflammatory, antifungal, and antimicrobial properties. Active compounds include triterpenoids and polysaccharides, as well as proteins, lipids, phenolics, sterols, etc. In the following review, we summarize briefly their biological activities, such as antioxidant, anti-bacterial, anti-fungal, antitumor, anti-viral, and anti-inflammatory activity. Although Ganoderma has a number of medicinal effects that have been confirmed by the in vitro and in vivo studies summarised in this review, there are some limitations. Clinical trials face mainly a lack of pure constituents. Accurate identification of the compounds obtained is also problematic. In addition, most of the included studies were small, and there were concerns about the methodological quality of each study. Studies have shown that Ganoderma has valuable potential for the prevention and treatment of cancer. In any case, G. lucidum cannot be used as first-line therapy for cancer.
Keywords:Ganoderma lucidum, bioactive function, active compounds, polysaccharides, triterpenoids
Publication status:Published
Publication version:Version of Record
Publication date:01.01.2022
Year of publishing:2022
Number of pages:14 str.
Numbering:Vol. 13
PID:20.500.12556/DKUM-85014 New window
UDC:577
ISSN on article:1663-9812
COBISS.SI-ID:116231939 New window
DOI:10.3389/fphar.2022.934982 New window
Publication date in DKUM:16.08.2023
Views:283
Downloads:30
Metadata:XML RDF-CHPDL DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in pharmacology
Shortened title:Front Pharmacol
Publisher:Frontiers Media
ISSN:1663-9812
COBISS.SI-ID:29551833 New window

Document is financed by a project

Funder:ARRS - Slovenian Research Agency
Project number:P2-0046
Name:Separacijski procesi in produktna tehnika

Funder:ARRS - Slovenian Research Agency
Project number:J2-1725
Name:Pametni materiali za bioaplikacije

Funder:ARRS - Slovenian Research Agency
Project number:L2-3175
Name:Napredna ekstrakcija in formulacija funkcionalnih taninskih prahranskih dopolnil z blagodejnimi zdravstvenimi učinki

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:bioaktivne funkcije, aktivne sestavine, polisaharidi


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica